Global Foot and Mouth Disease (FMD) Vaccines Market Outlook 2023

Report ID: 1128503 | Published Date: Jan 2025 | No. of Page: 131 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Foot and Mouth Disease (FMD) Vaccines Market Overview
    1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
    1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type
        1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Emergency Vaccines
        1.2.3 Conventional Vaccines
    1.3 Foot and Mouth Disease (FMD) Vaccines Segment by Application
        1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Comparison by Application: (2021-2027)
        1.3.2 Cattle
        1.3.3 Pig
        1.3.4 Sheep and Goat
        1.3.5 Others
    1.4 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2016-2027
        1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2016-2027
        1.4.3 Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Foot and Mouth Disease (FMD) Vaccines Market Competition by Manufacturers
    2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation and Trends
        2.5.1 Foot and Mouth Disease (FMD) Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue
        2.5.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario by Region
    3.1 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
        3.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country
        3.3.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
        3.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country
        3.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region
        3.5.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
        3.6.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country
        3.6.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country
        3.7.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Analysis by Type
    4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2021)
    4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2021)
    4.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021)

5 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Analysis by Application
    5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2021)
    5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2021)
    5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Jinyu Group
        6.1.1 Jinyu Group Corporation Information
        6.1.2 Jinyu Group Description and Business Overview
        6.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.1.5 Jinyu Group Recent Developments/Updates
    6.2 Cavet Bio
        6.2.1 Cavet Bio Corporation Information
        6.2.2 Cavet Bio Description and Business Overview
        6.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.2.5 Cavet Bio Recent Developments/Updates
    6.3 Indian Immunologicals
        6.3.1 Indian Immunologicals Corporation Information
        6.3.2 Indian Immunologicals Description and Business Overview
        6.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.3.5 Indian Immunologicals Recent Developments/Updates
    6.4 Tecon Group
        6.4.1 Tecon Group Corporation Information
        6.4.2 Tecon Group Description and Business Overview
        6.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.4.5 Tecon Group Recent Developments/Updates
    6.5 CAHIC
        6.5.1 CAHIC Corporation Information
        6.5.2 CAHIC Description and Business Overview
        6.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.5.5 CAHIC Recent Developments/Updates
    6.6 Shen Lian
        6.6.1 Shen Lian Corporation Information
        6.6.2 Shen Lian Description and Business Overview
        6.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.6.5 Shen Lian Recent Developments/Updates
    6.7 Biogenesis Bagó
        6.6.1 Biogenesis Bagó Corporation Information
        6.6.2 Biogenesis Bagó Description and Business Overview
        6.6.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.7.5 Biogenesis Bagó Recent Developments/Updates
    6.8 BIGVET Biotech
        6.8.1 BIGVET Biotech Corporation Information
        6.8.2 BIGVET Biotech Description and Business Overview
        6.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.8.5 BIGVET Biotech Recent Developments/Updates
    6.9 Boehringer Ingelheim
        6.9.1 Boehringer Ingelheim Corporation Information
        6.9.2 Boehringer Ingelheim Description and Business Overview
        6.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.9.5 Boehringer Ingelheim Recent Developments/Updates
    6.10 MSD Animal Health
        6.10.1 MSD Animal Health Corporation Information
        6.10.2 MSD Animal Health Description and Business Overview
        6.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.10.5 MSD Animal Health Recent Developments/Updates
    6.11 CEVA
        6.11.1 CEVA Corporation Information
        6.11.2 CEVA Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.11.5 CEVA Recent Developments/Updates
    6.12 FGBI
        6.12.1 FGBI Corporation Information
        6.12.2 FGBI Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.12.5 FGBI Recent Developments/Updates
    6.13 Bayer HealthCare
        6.13.1 Bayer HealthCare Corporation Information
        6.13.2 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.13.5 Bayer HealthCare Recent Developments/Updates
    6.14 Brilliant Bio Pharma
        6.14.1 Brilliant Bio Pharma Corporation Information
        6.14.2 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.14.5 Brilliant Bio Pharma Recent Developments/Updates
    6.15 VECOL
        6.15.1 VECOL Corporation Information
        6.15.2 VECOL Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.15.5 VECOL Recent Developments/Updates
    6.16 Sanofi (Merial)
        6.16.1 Sanofi (Merial) Corporation Information
        6.16.2 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.16.5 Sanofi (Merial) Recent Developments/Updates
    6.17 VETAL
        6.17.1 VETAL Corporation Information
        6.17.2 VETAL Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.17.5 VETAL Recent Developments/Updates
    6.18 BVI
        6.18.1 BVI Corporation Information
        6.18.2 BVI Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.18.5 BVI Recent Developments/Updates
    6.19 LIMOR
        6.19.1 LIMOR Corporation Information
        6.19.2 LIMOR Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.19.5 LIMOR Recent Developments/Updates
    6.20 ME VAC
        6.20.1 ME VAC Corporation Information
        6.20.2 ME VAC Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.20.5 ME VAC Recent Developments/Updates
    6.21 Agrovet
        6.21.1 Agrovet Corporation Information
        6.21.2 Agrovet Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
        6.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
        6.21.5 Agrovet Recent Developments/Updates

7 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis
    7.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
    7.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Foot and Mouth Disease (FMD) Vaccines Distributors List
    8.3 Foot and Mouth Disease (FMD) Vaccines Customers

9 Foot and Mouth Disease (FMD) Vaccines Market Dynamics
    9.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
    9.2 Foot and Mouth Disease (FMD) Vaccines Growth Drivers
    9.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
    9.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints

10 Global Market Forecast
    10.1 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Type (2022-2027)
    10.2 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Application (2022-2027)
    10.3 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) Comparison by Application (2021-2027)
    Table 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Covered in This Study
    Table 5. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Foot and Mouth Disease (FMD) Vaccines Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (M Doses)
    Table 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
    Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 19. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
    Table 20. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
    Table 22. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 23. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
    Table 24. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (M Doses)
    Table 27. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 31. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
    Table 32. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 35. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
    Table 38. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) by Type (2016-2021)
    Table 39. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2021)
    Table 40. Global Foot and Mouth Disease (FMD) Vaccines Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2016-2021)
    Table 42. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/K Doses) by Type (2016-2021)
    Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) by Application (2016-2021)
    Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2021)
    Table 45. Global Foot and Mouth Disease (FMD) Vaccines Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2016-2021)
    Table 47. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/K Doses) by Application (2016-2021)
    Table 48. Jinyu Group Corporation Information
    Table 49. Jinyu Group Description and Business Overview
    Table 50. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 51. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
    Table 52. Jinyu Group Recent Developments/Updates
    Table 53. Cavet Bio Corporation Information
    Table 54. Cavet Bio Description and Business Overview
    Table 55. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 56. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
    Table 57. Cavet Bio Recent Developments/Updates
    Table 58. Indian Immunologicals Corporation Information
    Table 59. Indian Immunologicals Description and Business Overview
    Table 60. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 61. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
    Table 62. Indian Immunologicals Recent Developments/Updates
    Table 63. Tecon Group Corporation Information
    Table 64. Tecon Group Description and Business Overview
    Table 65. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 66. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
    Table 67. Tecon Group Recent Developments/Updates
    Table 68. CAHIC Corporation Information
    Table 69. CAHIC Description and Business Overview
    Table 70. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 71. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
    Table 72. CAHIC Recent Developments/Updates
    Table 73. Shen Lian Corporation Information
    Table 74. Shen Lian Description and Business Overview
    Table 75. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 76. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
    Table 77. Shen Lian Recent Developments/Updates
    Table 78. Biogenesis Bagó Corporation Information
    Table 79. Biogenesis Bagó Description and Business Overview
    Table 80. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 81. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
    Table 82. Biogenesis Bagó Recent Developments/Updates
    Table 83. BIGVET Biotech Corporation Information
    Table 84. BIGVET Biotech Description and Business Overview
    Table 85. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 86. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
    Table 87. BIGVET Biotech Recent Developments/Updates
    Table 88. Boehringer Ingelheim Corporation Information
    Table 89. Boehringer Ingelheim Description and Business Overview
    Table 90. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 91. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
    Table 92. Boehringer Ingelheim Recent Developments/Updates
    Table 93. MSD Animal Health Corporation Information
    Table 94. MSD Animal Health Description and Business Overview
    Table 95. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 96. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product
    Table 97. MSD Animal Health Recent Developments/Updates
    Table 98. CEVA Corporation Information
    Table 99. CEVA Description and Business Overview
    Table 100. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 101. CEVA Foot and Mouth Disease (FMD) Vaccines Product
    Table 102. CEVA Recent Developments/Updates
    Table 103. FGBI Corporation Information
    Table 104. FGBI Description and Business Overview
    Table 105. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 106. FGBI Foot and Mouth Disease (FMD) Vaccines Product
    Table 107. FGBI Recent Developments/Updates
    Table 108. Bayer HealthCare Corporation Information
    Table 109. Bayer HealthCare Description and Business Overview
    Table 110. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 111. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product
    Table 112. Bayer HealthCare Recent Developments/Updates
    Table 113. Brilliant Bio Pharma Corporation Information
    Table 114. Brilliant Bio Pharma Description and Business Overview
    Table 115. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 116. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product
    Table 117. Brilliant Bio Pharma Recent Developments/Updates
    Table 118. VECOL Corporation Information
    Table 119. VECOL Description and Business Overview
    Table 120. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 121. VECOL Foot and Mouth Disease (FMD) Vaccines Product
    Table 122. VECOL Recent Developments/Updates
    Table 123. Sanofi (Merial) Corporation Information
    Table 124. Sanofi (Merial) Description and Business Overview
    Table 125. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 126. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product
    Table 127. Sanofi (Merial) Recent Developments/Updates
    Table 128. VETAL Corporation Information
    Table 129. VETAL Description and Business Overview
    Table 130. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 131. VETAL Foot and Mouth Disease (FMD) Vaccines Product
    Table 132. VETAL Recent Developments/Updates
    Table 133. BVI Corporation Information
    Table 134. BVI Description and Business Overview
    Table 135. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 136. BVI Foot and Mouth Disease (FMD) Vaccines Product
    Table 137. BVI Recent Developments/Updates
    Table 138. LIMOR Corporation Information
    Table 139. LIMOR Description and Business Overview
    Table 140. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 141. LIMOR Foot and Mouth Disease (FMD) Vaccines Product
    Table 142. LIMOR Recent Developments/Updates
    Table 143. ME VAC Corporation Information
    Table 144. ME VAC Description and Business Overview
    Table 145. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 146. ME VAC Foot and Mouth Disease (FMD) Vaccines Product
    Table 147. ME VAC Recent Developments/Updates
    Table 148. Agrovet Corporation Information
    Table 149. Agrovet Description and Business Overview
    Table 150. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 151. Agrovet Foot and Mouth Disease (FMD) Vaccines Product
    Table 152. Agrovet Recent Developments/Updates
    Table 153. Production Base and Market Concentration Rate of Raw Material
    Table 154. Key Suppliers of Raw Materials
    Table 155. Foot and Mouth Disease (FMD) Vaccines Distributors List
    Table 156. Foot and Mouth Disease (FMD) Vaccines Customers List
    Table 157. Foot and Mouth Disease (FMD) Vaccines Market Trends
    Table 158. Foot and Mouth Disease (FMD) Vaccines Growth Drivers
    Table 159. Foot and Mouth Disease (FMD) Vaccines Market Challenges
    Table 160. Foot and Mouth Disease (FMD) Vaccines Market Restraints
    Table 161. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
    Table 162. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Type (2022-2027)
    Table 163. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 164. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Type (2022-2027)
    Table 165. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
    Table 166. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Application (2022-2027)
    Table 167. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 168. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Application (2022-2027)
    Table 169. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
    Table 170. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Region (2022-2027)
    Table 171. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 172. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Region (2022-2027)
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Foot and Mouth Disease (FMD) Vaccines
    Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Type in 2020 & 2027
    Figure 3. Emergency Vaccines Product Picture
    Figure 4. Conventional Vaccines Product Picture
    Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application in 2020 & 2027
    Figure 6. Cattle
    Figure 7. Pig
    Figure 8. Sheep and Goat
    Figure 9. Others
    Figure 10. Global Foot and Mouth Disease (FMD) Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Market Size 2016-2027 (US$ Million)
    Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Sales 2016-2027 (M Doses)
    Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers in 2020
    Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Foot and Mouth Disease (FMD) Vaccines Players: Market Share by Revenue in 2020
    Figure 17. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
    Figure 19. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region in 2020
    Figure 20. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
    Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region in 2020
    Figure 22. U.S. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. China Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. UAE Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2016-2021)
    Figure 45. Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Application (2016-2021)
    Figure 46. Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Application in 2020
    Figure 47. Revenue Share of Foot and Mouth Disease (FMD) Vaccines by Application (2016-2021)
    Figure 48. Revenue Share of Foot and Mouth Disease (FMD) Vaccines by Application in 2020
    Figure 49. Manufacturing Cost Structure of Foot and Mouth Disease (FMD) Vaccines
    Figure 50. Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
    Figure 51. Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet
Frequently Asked Questions
Foot and Mouth Disease (FMD) Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Foot and Mouth Disease (FMD) Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Foot and Mouth Disease (FMD) Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports